Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2022

View Archived Issues

NF1 mutation impacts neurons to modify tumor predisposition by increasing neuronal excitability

Arvinas Operations describes PROTACs for androgen receptor degradation

New tachykinin NK2 receptor agonists identified at Embark Biotech

New IL-17 modulators discovered at UCB

Zydus Lifesciences patents bacterial dihydrofolate reductase inhibitors

Betta Pharmaceuticals describes histone acetyltransferase KAT3B inhibitors

Artemisinin derivatives as potential agents for the treatment of MS

Anti-NOTCH3 treatment reverses experimental pulmonary arterial hypertension

Cat model of Rdh5-associated retinopathy mimics the human phenotype

Close look illuminates ketamine's (relative) staying power

Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm

SRSF9 overexpression correlates with CRC lymph node metastasis and Dukes stage

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026